AI-led internal programs, and an aptamer based diagnostics pipeline
Internal therapeutic programs, and an aptamer based diagnostics pipeline, driven by the same discovery engine.
Our Discovery AI engine is already building
new therapies
Research and diagnostics is where our platform proves itself. By using our own data, and working in our own laboratories, our skilled team run internal therapeutic and diagnostic discovery programs. This builds value directly, and demonstrates the effectiveness of the engine that our customers and partners can also use.
How genuine advantage can be gained to deliver innovative healthcare solutions
We run our own discovery programs using Discovery AI, targeting conditions where RNA and DNA approaches offer genuine advantage over existing standards of care. Programs focus on rapid candidate generation, biomarker work, and clinical trial readiness, spanning areas such as neurological disease, infectious disease, cardiometabolic disease, and oncology.
High-need therapeutic areas designed and constantly assessed
Discovery AI is actively designing antisense oligonucleotide and RNA silencing candidates across several high need therapeutic areas, designed from the outset for manufacturability, and biomarker and endpoint readiness. Programs are described in general terms while they progress through discovery and validation.
Stable, synthetic, and highly specific
We use Discovery AI to design aptamer based point of care diagnostic tests built on molecular signatures. Aptamers are stable, synthetic, and highly specific, which makes them well suited to rapid, point of care formats. Our pipeline spans a range of high need conditions, with programs advancing through design and validation.
Proof the engine works
Our first AI candidate was fully designed by Discovery AI and has entered laboratory validation. It’s our first candidate to complete the full discovery to laboratory workflow. This is the validation that the platform works and can take a program from being a target to a real, testable molecule.
Reap the benefits of an integrated life sciences company
Talk to our team about your program, from candidate design to trial-ready material.